{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:13:21Z","timestamp":1793121201699,"version":"4.5.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.intimp.2023.109697","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T17:45:29Z","timestamp":1674236729000},"page":"109697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["The role of NLRP3 inflammasome in sepsis: A potential therapeutic target"],"prefix":"10.1016","volume":"115","author":[{"given":"Wenfang","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4174-1994","authenticated-orcid":false,"given":"Jinxiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2023.109697_b0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.intimp.2023.109697_b0010","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00134-020-06151-x","article-title":"Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis","volume":"46","author":"Fleischmann-Struzek","year":"2020","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.intimp.2023.109697_b0015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2213-2600(14)70061-X","article-title":"ICON investigators, Assessment of the worldwide burden of critical illness: the intensive care over nations (ICON) audit","volume":"2","author":"Vincent","year":"2014","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.intimp.2023.109697_b0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the Global Burden of Disease Study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.intimp.2023.109697_b0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2017.17687","article-title":"Enhancing Recovery From Sepsis: A Review","volume":"319","author":"Prescott","year":"2018","journal-title":"JAMA."},{"key":"10.1016\/j.intimp.2023.109697_b0030","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1056\/NEJMp1707170","article-title":"Recognizing Sepsis as a Global Health Priority - A WHO Resolution","volume":"377","author":"Reinhart","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"2017","key":"10.1016\/j.intimp.2023.109697_b0035","first-page":"486","volume":"45","author":"A. Rhodes, L.E. Evans, W. Alhazzani, M.M. Levy, M. Antonelli, R. Ferrer, A. Kumar, J.E. Sevransky, C.L. Sprung, M.E. Nunnally, B. Rochwerg, G.D. Rubenfeld, D.C. Angus, D. Annane, R.J. Beale, G.J. Bellinghan, G.R. Bernard, J.-D. Chiche, C. Coopersmith, D.P. De Backer, C.J. French, S. Fujishima, H. Gerlach, J.L. Hidalgo, S.M. Hollenberg, A.E. Jones, D.R. Karnad, R.M. Kleinpell, Y. Koh, T.C. Lisboa, F.R. Machado, J.J. Marini, J.C. Marshall, J.E. Mazuski, L.A. McIntyre, A.S. McLean, S. Mehta, R.P. Moreno, J. Myburgh, P. Navalesi, O. Nishida, T.M. Osborn, A. Perner, C.M. Plunkett, M. Ranieri, C.A. Schorr, M.A. Seckel, C.W. Seymour, L. Shieh, K.A. Shukri, S.Q. Simpson, M. Singer, B.T. Thompson, S.R. Townsend, T. Van der Poll, J.-L. Vincent, W.J. Wiersinga, J.L. Zimmerman, R.P. Dellinger, Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock","year":"2016","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2023.109697_b0040","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1089\/sur.2017.298","article-title":"Multiple Organ Dysfunction: The Defining Syndrome of Sepsis","volume":"19","author":"Ziesmann","year":"2018","journal-title":"Surg. Infect."},{"key":"10.1016\/j.intimp.2023.109697_b0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4161\/viru.25436","article-title":"Host innate immune responses to sepsis","volume":"5","author":"Wiersinga","year":"2014","journal-title":"Virulence."},{"key":"10.1016\/j.intimp.2023.109697_b0050","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.3390\/vaccines5040034","article-title":"TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis","volume":"5","author":"Kuzmich","year":"2017","journal-title":"Vaccines."},{"key":"10.1016\/j.intimp.2023.109697_b0055","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2147\/JIR.S178084","article-title":"Inflammasomes: Pandora\u2019s box for sepsis","volume":"11","author":"Kumar","year":"2018","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.intimp.2023.109697_b0060","first-page":"30","article-title":"Pathophysiology of sepsis-induced myocardial dysfunction","volume":"3","author":"Lv","year":"2016","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.intimp.2023.109697_b0065","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13054-018-2051-8","article-title":"Acute lung injury: how to stabilize a broken lung","volume":"22","author":"Nieman","year":"2018","journal-title":"Crit. Care Lond. Engl."},{"key":"10.1016\/j.intimp.2023.109697_b0070","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/j.gastro.2018.12.033","article-title":"Epidemiology, Pathophysiology, and Treatment of Diverticulitis","volume":"156","author":"Strate","year":"2019","journal-title":"Gastroenterology."},{"key":"10.1016\/j.intimp.2023.109697_b0075","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrneurol.2012.183","article-title":"Sepsis-associated encephalopathy","volume":"8","author":"Gofton","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.intimp.2023.109697_b0080","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s44161-022-00108-7","article-title":"Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis","volume":"1","author":"Su","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.intimp.2023.109697_b0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell."},{"key":"10.1016\/j.intimp.2023.109697_b0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1074-7613(04)00046-9","article-title":"NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder","volume":"20","author":"Agostini","year":"2004","journal-title":"Immunity."},{"key":"10.1016\/j.intimp.2023.109697_b0095","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nrd.2018.97","article-title":"Targeting the NLRP3 inflammasome in inflammatory diseases","volume":"17","author":"Mangan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2023.109697_b0100","first-page":"737","article-title":"The Pathogenic Role of NLRP3 Inflammasome Activation in Inflammatory Bowel Diseases of Both Mice and Humans","volume":"11","author":"Liu","year":"2017","journal-title":"J. Crohns Colitis."},{"key":"10.1016\/j.intimp.2023.109697_b0105","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.109697_b0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","article-title":"Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome","volume":"29","author":"Hoffman","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.intimp.2023.109697_b0115","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1002\/art.10509","article-title":"Association of mutations in the NALP3\/CIAS1\/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis","volume":"46","author":"Aganna","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2023.109697_b0120","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2023.109697_b0125","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nri.2016.151","article-title":"Homeostasis-altering molecular processes as mechanisms of inflammasome activation","volume":"17","author":"Liston","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0130","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2023.109697_b0135","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1084\/jem.20160933","article-title":"NLRP3 inflammasome assembly is regulated by phosphorylation of the pyrin domain","volume":"214","author":"Stutz","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.109697_b0140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"issue":"199","key":"10.1016\/j.intimp.2023.109697_b0145","first-page":"1561","article-title":"Cutting Edge: TRAF6 Mediates TLR\/IL-1R Signaling-Induced Nontranscriptional Priming of the NLRP3 Inflammasome","volume":"1950","author":"Xing","year":"2017","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.intimp.2023.109697_b0150","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ni.3772","article-title":"Limiting inflammation-the negative regulation of NF-\u03baB and the NLRP3 inflammasome","volume":"18","author":"Afonina","year":"2017","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0155","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0160","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ni.1636","article-title":"The NALP3 inflammasome is involved in the innate immune response to amyloid-beta","volume":"9","author":"Halle","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0952-7915(02)00017-1","article-title":"New insights into the mechanism of IL-1beta maturation","volume":"15","author":"Burns","year":"2003","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0170","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and Regulation of NLRP3 Inflammasome Activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.intimp.2023.109697_b0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.immuni.2018.04.032","article-title":"The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-induced Inflammation","volume":"49","author":"Di","year":"2018","journal-title":"Immunity."},{"key":"10.1016\/j.intimp.2023.109697_b0180","article-title":"NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx","volume":"311","author":"Ma","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.intimp.2023.109697_b0185","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1002\/eji.201545772","article-title":"Caspase-11 activates a canonical NLRP3 inflammasome by promoting K(+) efflux","volume":"45","author":"R\u00fchl","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0190","doi-asserted-by":"crossref","first-page":"11282","DOI":"10.1073\/pnas.1117765109","article-title":"Critical role for calcium mobilization in activation of the NLRP3 inflammasome","volume":"109","author":"Murakami","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"194","key":"10.1016\/j.intimp.2023.109697_b0195","first-page":"3937","article-title":"K+ efflux agonists induce NLRP3 inflammasome activation independently of Ca2+ signaling","volume":"1950","author":"Katsnelson","year":"2015","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.intimp.2023.109697_b0200","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcell.2020.00167","article-title":"Cathepsin B Is Required for NLRP3 Inflammasome Activation in Macrophages, Through NLRP3 Interaction","volume":"8","author":"Chevriaux","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2023.109697_b0205","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41419-018-0378-3","article-title":"Hydroxychloroquine attenuates renal ischemia\/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation","volume":"9","author":"Tang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2023.109697_b0210","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.yexcr.2017.11.015","article-title":"Cathepsin B links oxidative stress to the activation of NLRP3 inflammasome","volume":"362","author":"Bai","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.intimp.2023.109697_b0215","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2023.109697_b0220","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science."},{"key":"10.1016\/j.intimp.2023.109697_b0225","doi-asserted-by":"crossref","first-page":"e0182022","DOI":"10.1371\/journal.pone.0182022","article-title":"Imidazoquinoxaline anticancer derivatives and imiquimod interact with tubulin: Characterization of molecular microtubule inhibiting mechanisms in correlation with cytotoxicity","volume":"12","author":"Courbet","year":"2017","journal-title":"PloS One."},{"key":"10.1016\/j.intimp.2023.109697_b0230","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.immuni.2016.08.010","article-title":"K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria","volume":"45","author":"Gro\u00df","year":"2016","journal-title":"Immunity."},{"key":"10.1016\/j.intimp.2023.109697_b0235","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasome activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2023.109697_b0240","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity."},{"key":"10.1016\/j.intimp.2023.109697_b0245","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/ars.2015.6615","article-title":"Nuclear Factor E2-Related Factor-2 Negatively Regulates NLRP3 Inflammasome Activity by Inhibiting Reactive Oxygen Species-Induced NLRP3 Priming","volume":"26","author":"Liu","year":"2017","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.intimp.2023.109697_b0250","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bcp.2008.07.017","article-title":"Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis","volume":"76","author":"Li","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109697_b0255","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2023.109697_b0260","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature13683","article-title":"Inflammatory caspases are innate immune receptors for intracellular LPS","volume":"514","author":"Shi","year":"2014","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2023.109697_b0265","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2023.109697_b0270","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2023.109697_b0275","doi-asserted-by":"crossref","first-page":"eaar6676","DOI":"10.1126\/sciimmunol.aar6676","article-title":"Noncanonical inflammasome signaling elicits gasdermin D-dependent neutrophil extracellular traps","volume":"3","author":"Chen","year":"2018","journal-title":"Sci. Immunol."},{"issue":"190","key":"10.1016\/j.intimp.2023.109697_b0280","first-page":"1217","article-title":"Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages","volume":"1950","author":"Kahlenberg","year":"2013","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.intimp.2023.109697_b0285","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrd3800","article-title":"Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases","volume":"11","author":"Dinarello","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2023.109697_b0290","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-med-061512-150641","article-title":"IL-1 blockade in autoinflammatory syndromes","volume":"65","author":"Jesus","year":"2014","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.intimp.2023.109697_b0295","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1345\/aph.1A396","article-title":"Anakinra treatment of patients with rheumatoid arthritis","volume":"36","author":"Calabrese","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.intimp.2023.109697_b0300","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13023-015-0228-7","article-title":"MAIL1 (Maladies Auto-inflammatoires et Anti-IL-1) study Group on behalf of CRI (Club Rhumatisme et Inflammation), Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey","volume":"10","author":"Rossi-Semerano","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.intimp.2023.109697_b0305","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/14740338.2018.1486819","article-title":"Anakinra for the treatment of rheumatoid arthritis: a safety evaluation","volume":"17","author":"Ram\u00edrez","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.intimp.2023.109697_b0310","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/rheumatology\/ker146","article-title":"British Society for Rheumatology Biologics Register, The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register","volume":"50","author":"J.B. Galloway, K.L. Hyrich, L.K. Mercer, W.G. Dixon, K.D. Watson, M. Lunt, BSRBR Control Centre Consortium, D.P.M. Symmons","year":"2011","journal-title":"Rheumatol. Oxf. Engl."},{"key":"10.1016\/j.intimp.2023.109697_b0315","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"CANTOS Trial Group, Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.109697_b0320","doi-asserted-by":"crossref","unstructured":"C.J. Fisher, J.F. Dhainaut, S.M. Opal, J.P. Pribble, R.A. Balk, G.J. Slotman, T.J. Iberti, E.C. Rackow, M.J. Shapiro, R.L. Greenman, Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group, JAMA. 271 (1994) 1836\u20131843.","DOI":"10.1001\/jama.271.23.1836"},{"key":"10.1016\/j.intimp.2023.109697_b0325","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00003246-199707000-00010","article-title":"Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group","volume":"25","author":"Opal","year":"1997","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2023.109697_b0330","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","article-title":"Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial","volume":"44","author":"Shakoory","year":"2016","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2023.109697_b0335","doi-asserted-by":"crossref","first-page":"248-+","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2023.109697_b0340","first-page":"E522","article-title":"Inhibiting the NLRP3 Inflammasome Activation with MCC950 Ameliorates Diabetic Encephalopathy in db\/db Mice","volume":"23","author":"Zhai","year":"2018","journal-title":"Mol. Basel Switz."},{"key":"10.1016\/j.intimp.2023.109697_b0345","doi-asserted-by":"crossref","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109697_b0350","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/ATVBAHA.117.309575","article-title":"NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report","volume":"37","author":"van der Heijden","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2023.109697_b0355","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1021\/acschembio.1c00218","article-title":"A Probe for NLRP3 Inflammasome Inhibitor MCC950 Identifies Carbonic Anhydrase 2 as a Novel Target","volume":"16","author":"Kennedy","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.intimp.2023.109697_b0360","first-page":"568","article-title":"The potential for caspases in drug discovery","volume":"13","author":"MacKenzie","year":"2010","journal-title":"Curr. Opin. Drug Discov. Devel."},{"key":"10.1016\/j.intimp.2023.109697_b0365","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/acschemneuro.7b00124","article-title":"Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 Inflammasome Inhibitor for Potential Treatment of Multiple Sclerosis","volume":"8","author":"Guo","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.intimp.2023.109697_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107358","article-title":"NLRP3 inflammasome inhibitor INF39 attenuated NLRP3 assembly in macrophages","volume":"92","author":"Shi","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109697_b0375","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.intimp.2023.109697_b0380","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2023.109697_b0385","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/ni.2913","article-title":"ASC has extracellular and prionoid activities that propagate inflammation","volume":"15","author":"Franklin","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102696","article-title":"Spirodalesol analog 8A inhibits NLRP3 inflammasome activation and attenuates inflammatory disease by directly targeting adaptor protein ASC","volume":"298","author":"Liu","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2023.109697_b0395","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/jcbfm.2009.46","article-title":"Therapeutic neutralization of the NLRP1 inflammasome reduces the innate immune response and improves histopathology after traumatic brain injury","volume":"29","author":"de Rivero Vaccari","year":"2009","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.intimp.2023.109697_b0400","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/ni.2749","article-title":"Phosphorylation of ASC acts as a molecular switch controlling the formation of speck-like aggregates and inflammasome activity","volume":"14","author":"Hara","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0405","doi-asserted-by":"crossref","first-page":"36214","DOI":"10.1038\/srep36214","article-title":"Pyk2 activates the NLRP3 inflammasome by directly phosphorylating ASC and contributes to inflammasome-dependent peritonitis","volume":"6","author":"Chung","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.109697_b0410","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.837180","article-title":"Pharmacological Inhibition of FAK-Pyk2 Pathway Protects Against Organ Damage and Prolongs the Survival of Septic Mice","volume":"13","author":"Alves","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0415","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.109697_b0420","doi-asserted-by":"crossref","first-page":"9792","DOI":"10.1074\/jbc.M109.082305","article-title":"Anti-inflammatory compounds parthenolide and Bay 11\u20137082 are direct inhibitors of the inflammasome","volume":"285","author":"Juliana","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2023.109697_b0425","doi-asserted-by":"crossref","first-page":"18509","DOI":"10.1002\/jcb.29173","article-title":"Dexmedetomidine alleviates lipopolysaccharide-induced acute kidney injury by inhibiting the NLRP3 inflammasome activation via regulating the TLR4\/NOX4\/NF-\u03baB pathway","volume":"120","author":"Yao","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.intimp.2023.109697_b0430","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s10753-018-0894-4","article-title":"NLRP3\/Caspase-1 Pathway-Induced Pyroptosis Mediated Cognitive Deficits in a Mouse Model of Sepsis-Associated Encephalopathy","volume":"42","author":"Fu","year":"2019","journal-title":"Inflammation."},{"key":"10.1016\/j.intimp.2023.109697_b0435","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/jcp.24903","article-title":"Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy","volume":"230","author":"Chang","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2023.109697_b0440","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11011-018-0348-6","article-title":"Intracerebroventricular injection of resveratrol ameliorated A\u03b2-induced learning and cognitive decline in mice","volume":"34","author":"Qi","year":"2019","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.intimp.2023.109697_b0445","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.intimp.2017.06.029","article-title":"Resveratrol alleviates cerebral ischemia\/reperfusion injury in rats by inhibiting NLRP3 inflammasome activation through Sirt1-dependent autophagy induction","volume":"50","author":"He","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109697_b0450","first-page":"4131","article-title":"Resveratrol attenuates neurological deficit and neuroinflammation following intracerebral hemorrhage","volume":"15","author":"Cai","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2023.109697_b0455","doi-asserted-by":"crossref","first-page":"1045657","DOI":"10.1155\/2016\/1045657","article-title":"Resveratrol Protects against Sepsis-Associated Encephalopathy and Inhibits the NLRP3\/IL-1\u03b2 Axis in Microglia","volume":"2016","author":"Sui","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2023.109697_b0460","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1080\/08923973.2017.1355377","article-title":"Inhibition of NLRP3 inflammasome: a new protective mechanism of cinnamaldehyde in endotoxin poisoning of mice","volume":"39","author":"Xu","year":"2017","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"10.1016\/j.intimp.2023.109697_b0465","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s10753-019-00990-7","article-title":"Dihydromyricetin Alleviates Sepsis-Induced Acute Lung Injury through Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis in Mice Model","volume":"42","author":"Wang","year":"2019","journal-title":"Inflammation."},{"key":"10.1016\/j.intimp.2023.109697_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175047","article-title":"Fudosteine attenuates acute lung injury in septic mice by inhibiting pyroptosis via the TXNIP\/NLRP3\/GSDMD pathway","volume":"926","author":"He","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2023.109697_b0475","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.intimp.2015.10.017","article-title":"Hyperin attenuates inflammation by activating PPAR-\u03b3 in mice with acute liver injury (ALI) and LPS-induced RAW264.7 cells","volume":"29","author":"Huang","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109697_b0480","doi-asserted-by":"crossref","first-page":"82602","DOI":"10.18632\/oncotarget.13010","article-title":"Hyperin protects against LPS-induced acute kidney injury by inhibiting TLR4 and NLRP3 signaling pathways","volume":"7","author":"Chunzhi","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.intimp.2023.109697_b0485","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nature02664","article-title":"Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf","volume":"430","author":"Mariathasan","year":"2004","journal-title":"Nature."},{"key":"10.1016\/j.intimp.2023.109697_b0490","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1038\/s41467-018-06522-5","article-title":"Targeting of NLRP3 inflammasome with gene editing for the amelioration of inflammatory diseases","volume":"9","author":"Xu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2023.109697_b0495","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/imm.12450","article-title":"Improved emergency myelopoiesis and survival in neonatal sepsis by caspase-1\/11 ablation","volume":"145","author":"Gentile","year":"2015","journal-title":"Immunology."},{"issue":"198","key":"10.1016\/j.intimp.2023.109697_b0500","first-page":"1253","article-title":"Deletion of Nlrp3 Augments Survival during Polymicrobial Sepsis by Decreasing Autophagy and Enhancing Phagocytosis","volume":"1950","author":"Jin","year":"2017","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.intimp.2023.109697_b0505","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/rccm.201604-0892OC","article-title":"NLRP3 Inflammasome Deficiency Protects against Microbial Sepsis via Increased Lipoxin B4 Synthesis","volume":"196","author":"Lee","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2023.109697_b0510","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.molimm.2020.03.020","article-title":"The roles of NLRP3 inflammasome in bacterial infection","volume":"122","author":"Zhong","year":"2020","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0515","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/mi.2017.50","article-title":"NLRP3 inflammasome pathway has a critical role in the host immunity against clinically relevant Acinetobacter baumannii pulmonary infection","volume":"11","author":"Dikshit","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0520","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.immuni.2017.07.007","article-title":"Understanding Immunosuppression after Sepsis","volume":"47","author":"Fattahi","year":"2017","journal-title":"Immunity."},{"key":"10.1016\/j.intimp.2023.109697_b0525","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra1608077","article-title":"Acute Respiratory Distress Syndrome","volume":"377","author":"Thompson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2023.109697_b0530","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/CCM.0000000000003023","article-title":"The Impact of Acute Organ Dysfunction on Long-Term Survival in Sepsis","volume":"46","author":"Schuler","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2023.109697_b0535","first-page":"CD004477","article-title":"Pharmacological agents for adults with acute respiratory distress syndrome","volume":"7","author":"Lewis","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2023.109697_b0540","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.intimp.2015.04.035","article-title":"Blockage of P2X7 attenuates acute lung injury in mice by inhibiting NLRP3 inflammasome","volume":"27","author":"Wang","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"192","key":"10.1016\/j.intimp.2023.109697_b0545","first-page":"5974","article-title":"Critical role for the NLRP3 inflammasome during acute lung injury","volume":"1950","author":"Grailer","year":"2014","journal-title":"J. Immunol. Baltim. Md"},{"key":"10.1016\/j.intimp.2023.109697_b0550","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.omtn.2019.08.028","article-title":"NLRP3 Inflammasome Activation by MicroRNA-495 Promoter Methylation May Contribute to the Progression of Acute Lung Injury","volume":"18","author":"Ying","year":"2019","journal-title":"Mol. Ther. Nucleic Acids."},{"key":"10.1016\/j.intimp.2023.109697_b0555","article-title":"Vasoactive intestinal peptide suppresses the NLRP3 inflammasome activation in lipopolysaccharide-induced acute lung injury mice and macrophages","volume":"121","author":"Zhou","year":"2020","journal-title":"Biomed. Pharmacother. Biomedecine Pharmacother."},{"key":"10.1016\/j.intimp.2023.109697_b0560","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.foodchem.2014.09.090","article-title":"Antioxidant activities of Vine Tea (Ampelopsis grossedentata) extract and its major component dihydromyricetin in soybean oil and cooked ground beef","volume":"172","author":"Ye","year":"2015","journal-title":"Food Chem."},{"key":"10.1016\/j.intimp.2023.109697_b0565","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.jcrc.2014.03.028","article-title":"Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment","volume":"29","author":"Antonucci","year":"2014","journal-title":"J. Crit. Care."},{"key":"10.1016\/j.intimp.2023.109697_b0570","doi-asserted-by":"crossref","first-page":"e107639","DOI":"10.1371\/journal.pone.0107639","article-title":"Cardiac Fibroblasts Contribute to Myocardial Dysfunction in Mice with Sepsis: The Role of NLRP3 Inflammasome Activation","volume":"9","author":"Zhang","year":"2014","journal-title":"PLOS ONE."},{"key":"10.1016\/j.intimp.2023.109697_b0575","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12410","article-title":"Melatonin administration to wild-type mice and nontreated NLRP3 mutant mice share similar inhibition of the inflammatory response during sepsis","volume":"63","author":"Rahim","year":"2017","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.intimp.2023.109697_b0580","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107388","article-title":"Contribution of the NLRP3\/IL-1\u03b2 axis to impaired vasodilation in sepsis through facilitation of eNOS proteolysis and the protective role of melatonin","volume":"93","author":"Hu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2023.109697_b0585","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1002\/jcsm.12763","article-title":"Inhibition of the NLRP3\/IL-1\u03b2 axis protects against sepsis-induced cardiomyopathy","volume":"12","author":"Busch","year":"2021","journal-title":"J. Cachexia Sarcopenia Muscle."},{"key":"10.1016\/j.intimp.2023.109697_b0590","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1002\/jcp.30186","article-title":"Targeting the TXNIP-NLRP3 interaction with PSSM1443 to suppress inflammation in sepsis-induced myocardial dysfunction","volume":"236","author":"Wang","year":"2021","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.intimp.2023.109697_b0595","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.779432","article-title":"GSDMD Mediates LPS-Induced Septic Myocardial Dysfunction by Regulating ROS-dependent NLRP3 Inflammasome Activation","volume":"9","author":"Dai","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.intimp.2023.109697_b0600","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/psyg.12794","article-title":"HMGB1 augments cognitive impairment in sepsis-associated encephalopathy by binding to MD-2 and promoting NLRP3-induced neuroinflammation","volume":"22","author":"Xiong","year":"2022","journal-title":"Psychogeriatrics."},{"key":"10.1016\/j.intimp.2023.109697_b0605","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s10020-020-00181-3","article-title":"Ethyl pyruvate protects against sepsis-associated encephalopathy through inhibiting the NLRP3 inflammasome","volume":"26","author":"Zhong","year":"2020","journal-title":"Mol. Med. Camb. Mass."},{"key":"10.1016\/j.intimp.2023.109697_b0610","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11011-022-01017-1","article-title":"miR-25-3p ameliorates SAE by targeting the TLR4\/NLRP3 axis","volume":"37","author":"Luo","year":"2022","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.intimp.2023.109697_b0615","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1089\/jir.2021.0241","article-title":"Caffeine Citrate Protects Against Sepsis-Associated Encephalopathy and Inhibits the UCP2\/NLRP3 Axis in Astrocytes","volume":"42","author":"Hu","year":"2022","journal-title":"J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res."},{"key":"10.1016\/j.intimp.2023.109697_b0620","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1080\/09168451.2016.1171697","article-title":"Anti-inflammatory activity of myricetin from Diospyros lotus through suppression of NF-\u03baB and STAT1 activation and Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated RAW264.7 macrophages","volume":"80","author":"Cho","year":"2016","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.intimp.2023.109697_b0625","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5114\/fn.2019.89856","article-title":"Myricitrin attenuates memory impairment in a rat model of sepsis-associated encephalopathy via the NLRP3\/Bax\/Bcl pathway","volume":"57","author":"Gong","year":"2019","journal-title":"Folia Neuropathol."},{"key":"10.1016\/j.intimp.2023.109697_b0630","doi-asserted-by":"crossref","first-page":"6717212","DOI":"10.1155\/2018\/6717212","article-title":"Hydrogen Sulfide Attenuates LPS-Induced Acute Kidney Injury by Inhibiting Inflammation and Oxidative Stress","volume":"2018","author":"Chen","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.intimp.2023.109697_b0635","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41420-022-00859-z","article-title":"Downregulation of macrophage migration inhibitory factor attenuates NLRP3 inflammasome mediated pyroptosis in sepsis-induced AKI","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2023.109697_b0640","first-page":"1","article-title":"Dexmedetomidine protects against lipopolysaccharide-induced early acute kidney injury by inhibiting the iNOS\/NO signaling pathway in rats, Nitric Oxide","volume":"85","author":"Chen","year":"2019","journal-title":"Biol. Chem."},{"key":"10.1016\/j.intimp.2023.109697_b0645","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41419-019-1416-5","article-title":"Dexmedetomidine inhibits astrocyte pyroptosis and subsequently protects the brain in in vitro and in vivo models of sepsis","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2023.109697_b0650","doi-asserted-by":"crossref","first-page":"e14073","DOI":"10.14814\/phy2.14073","article-title":"NLRP3 inflammasome activation in platelets in response to sepsis","volume":"7","author":"Cornelius","year":"2019","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.intimp.2023.109697_b0655","doi-asserted-by":"crossref","first-page":"e0234039","DOI":"10.1371\/journal.pone.0234039","article-title":"NLRP3 inflammasome inhibition attenuates sepsis-induced platelet activation and prevents multi-organ injury in cecal-ligation puncture","volume":"15","author":"Cornelius","year":"2020","journal-title":"PLoS ONE."},{"key":"10.1016\/j.intimp.2023.109697_b0660","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.3390\/ijms221910330","article-title":"Platelet Inhibition Prevents NLRP3 Inflammasome Activation and Sepsis-Induced Kidney Injury","volume":"22","author":"Borges-Rodriguez","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2023.109697_b0665","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/cei.12457","article-title":"Gene silencing of non-obese diabetic receptor family (NLRP3) protects against the sepsis-induced hyper-bile acidaemia in a rat model","volume":"179","author":"Wu","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2023.109697_b0670","first-page":"1269747","article-title":"PPAR\u03b3 Alleviates Sepsis-Induced Liver Injury by Inhibiting Hepatocyte Pyroptosis via Inhibition of the ROS\/TXNIP\/NLRP3 Signaling Pathway","volume":"2022","author":"Li","year":"2022","journal-title":"Oxid. Med. Cell. Longev."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923000206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T09:10:52Z","timestamp":1736413852000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923000206"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":134,"alternative-id":["S1567576923000206"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109697","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of NLRP3 inflammasome in sepsis: A potential therapeutic target","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.109697","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109697"}}